バイオアイデンティカルホルモンの世界市場レポート 2025年

バイオアイデンティカルホルモン市場規模は、今後数年間で力強い成長が見込まれます。2029年には102億米ドルに成長し、CAGRは6.3％となります。予測期間の成長は、女性の健康への関心の高まり、個別化医療の受け入れの拡大、政府の支援政策、慢性疾患の有病率の増加、バイオアイデンティカルホルモンの利点に対する意識の高まりに起因しています。予測期間における主な動向としては、新規バイオアイデンティカルホルモン製剤の開発、ホルモン療法相談のための遠隔医療の利用の増加、主流医療におけるバイオアイデンティカルホルモンの統合の増加、ホルモン送達システムの進歩、ホルモン生産におけるバイオテクノロジーの役割の拡大などが挙げられます。

個別化医療に対する需要の高まりは、バイオアイデンティカルホルモン市場の成長を促進すると予想されます。個別化医療は、遺伝学やライフスタイルなどの個人の特性に基づいて治療をカスタマイズし、有効性を高め、副作用を軽減するものです。このような需要の高まりは、より効果的な治療を提供する可能性、ゲノミクスの進歩、疾病の複雑化、規制当局のサポートなどに起因しています。バイオアイデンティカルホルモンは、患者固有のホルモン・プロファイルに適合させ、治療効果を向上させ、副作用を最小限に抑えることで、個別化医療を実現します。例えば、2024年2月、個別化医療連合（Personalized Medicine Coalition）は、FDAが2023年に希少疾患のための16の新しい個別化治療を承認し、2022年の6から増加したと報告しました。このように、個別化医療に対する需要の高まりが、バイオアイデンティカルホルモン市場に拍車をかけています。

バイオアイデンティカルホルモン市場の主要企業は、ホルモンバランスの乱れや関連する健康状態に対してより効果的で個別化された治療を提供するため、生物学的同一性ホルモン補充療法（BHRT）などの先進的ソリューションの開発に注力しています。BHRTは、人体で産生されるホルモンと化学的に同一のホルモンを使用し、ホルモンバランスの乱れや関連症状に対処します。例えば、2024年5月、インドの製薬会社ジャグソンパール・ファーマシューティカルズ・リミテッドは、米国FDA承認の生物学的同一性ホルモン療法であるメムアップHRTを発売しました。この治療法は、バイオアイデンティカル・エストラジオールとプロゲステロンを組み合わせた1錠のピルソリューションが特徴で、9つの地域言語でサポートが受けられます。今回の発売は、バイオアイデンティカルホルモンを活用してバランスのとれたホルモン補充を行い、患者のコンプライアンスを向上させることで、更年期管理に対する意識を高め、患者の転帰を改善し、インドの女性のヘルスケアの選択肢を広げることを目的としています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界バイオアイデンティカルホルモンPESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のバイオアイデンティカルホルモン市場：成長率分析
• 世界のバイオアイデンティカルホルモン市場の実績：規模と成長, 2019-2024
• 世界のバイオアイデンティカルホルモン市場の予測：規模と成長, 2024-2029, 2034F
• 世界バイオアイデンティカルホルモン総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のバイオアイデンティカルホルモン市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• エストロゲン
• プロゲステロン
• テストステロン
• その他のタイプ
• 世界のバイオアイデンティカルホルモン市場：製品タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 錠剤とカプセル
• クリームとジェル
• パッチとインプラント
• 注射剤
• その他の製品タイプ
• 世界のバイオアイデンティカルホルモン市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 小売薬局
• オンライン薬局
• その他の流通チャネル
• 世界のバイオアイデンティカルホルモン市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 更年期管理
• ホルモン補充療法（HRT）
• 甲状腺疾患
• 男性更年期障害の管理
• 世界のバイオアイデンティカルホルモン市場：最終用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 婦人科クリニック
• 調査室
• その他のエンドユーザー
• 世界のバイオアイデンティカルホルモン市場エストロゲンの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• エストロン（E1）
• エストラジオール（E2）
• エストリオール（E3）
• バイオアイデンティカルエストラジオールクリーム
• バイオアイデンティカルエストロンクリーム
• 世界のバイオアイデンティカルホルモン市場プロゲステロンの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• バイオアイデンティカルプロゲステロンクリーム
• バイオアイデンティカルプロゲステロンカプセル
• バイオアイデンティカルプロゲステロン注射
• 世界のバイオアイデンティカルホルモン市場テストステロンの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• バイオアイデンティカルテストステロンクリーム
• バイオアイデンティカルテストステロン注射
• バイオアイデンティカルテストステロンペレット
• バイオアイデンティカルテストステロンジェル
• 世界のバイオアイデンティカルホルモン市場、その他のタイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• Dhea（デヒドロエピアンドロステロン）
• 甲状腺ホルモン（T3、T4）
• コルチゾール
• メラトニン
• ヒト成長ホルモン（HGH）

第7章 地域別・国別分析

• 世界のバイオアイデンティカルホルモン市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のバイオアイデンティカルホルモン市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• バイオアイデンティカルホルモン市場：競合情勢
• バイオアイデンティカルホルモン市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Hikma Pharmaceuticals Plc
• TherapeuticsMD Inc.
• Gedeon Richter Plc
• Noven Pharmaceuticals Inc.
• AnazaoHealth Corp.
• Women's International Pharmacy Inc.
• Wells Pharmacy Network
• ZRT Laboratory LLC
• BionPharma Inc.
• Orion Pharma AB
• Actiza Pharmaceutical Private Limited
• Biostation
• Advantage Pharmaceuticals Inc.
• Bravado Labs
• Neuva Aesthetics

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• バイオアイデンティカルホルモン市場2029：新たな機会を提供する国
• バイオアイデンティカルホルモン市場2029：新たな機会を提供するセグメント
• バイオアイデンティカルホルモン市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Bioidentical hormones are identical in chemical structure to those naturally produced by the human body, often used in hormone replacement therapy to address imbalances. They are particularly effective in easing symptoms associated with menopause, andropause, and other hormonal deficiencies, such as hot flashes, night sweats, mood swings, and low libido.

The primary bioidentical hormones include estrogen, progesterone, testosterone, and others. Estrogen, a key female sex hormone, regulates reproductive and secondary sexual characteristics. These hormones are available in various forms such as tablets, capsules, creams, gels, patches, implants, and injectables. They are distributed through hospital pharmacies, retail pharmacies, online pharmacies, and other channels. Applications for bioidentical hormones include managing menopause, hormone replacement therapy (HRT), thyroid disorders, and andropause. They are utilized by diverse end-users such as hospitals, gynecology clinics, research laboratories, and others.

The bioidentical hormones market research report is one of a series of new reports from The Business Research Company that provides bioidentical hormones market statistics, including bioidentical hormones industry global market size, regional shares, competitors with a bioidentical hormones market share, detailed bioidentical hormones market segments, market trends and opportunities, and any further data you may need to thrive in the bioidentical hormones industry. This bioidentical hormones market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The bioidentical hormones market size has grown strongly in recent years. It will grow from $7.49 billion in 2024 to $7.99 billion in 2025 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to a rise in awareness of hormone-related health issues, increased prevalence of hormonal imbalances, increased aging population, increased healthcare expenditure, and increased demand for alternative medicine.

The bioidentical hormones market size is expected to see strong growth in the next few years. It will grow to $10.2 billion in 2029 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to increasing focus on women's health, growing acceptance of personalized medicine, supportive government policies, increasing prevalence of chronic diseases, and rising awareness of the benefits of bioidentical hormones. Major trends in the forecast period include the development of novel bioidentical hormone formulations, growing use of telemedicine for hormone therapy consultations, increasing integration of bioidentical hormones in mainstream medicine, advancements in hormone delivery systems, and the expanding role of biotechnology in hormone production.

The increasing demand for personalized medicine is anticipated to drive the growth of the bioidentical hormones market. Personalized medicine involves customizing medical treatment based on individual characteristics, such as genetics or lifestyle, to enhance effectiveness and reduce adverse effects. This growing demand stems from its potential to offer more effective treatments, advancements in genomics, increasing disease complexity, and regulatory support. Bioidentical hormones align with personalized medicine by matching a patient's specific hormonal profile, improving treatment efficacy, and minimizing side effects. For instance, in February 2024, the Personalized Medicine Coalition reported that the FDA approved 16 new personalized therapies for rare diseases in 2023, up from six in 2022. Thus, the rising demand for personalized medicine is fueling the bioidentical hormones market.

Leading companies in the bioidentical hormones market are focusing on developing advanced solutions such as bioidentical hormone replacement therapy (BHRT) to provide more effective and personalized treatments for hormonal imbalances and related health conditions. BHRT uses hormones that are chemically identical to those produced by the human body to address hormone imbalances and associated symptoms. For example, in May 2024, Jagsonpal Pharmaceuticals Limited, an Indian pharmaceutical company, launched MemUp HRT, a US FDA-approved bioidentical hormone therapy. This therapy features a single-pill solution combining bioidentical estradiol and progesterone, with support available in nine regional languages. This launch aims to leverage bioidentical hormones for balanced hormone replacement and improve patient compliance, thereby raising awareness about menopause management, enhancing patient outcomes, and expanding healthcare options for women in India.

In January 2024, BioTE Medical, LLC, a US-based healthcare company, acquired Asteria Health for $8.5 million. This acquisition strengthens BioTE's supply chain, enhances manufacturing capabilities, and improves its margin profile, positioning BioTE as a vertically integrated leader in the bioidentical hormones market and ensuring reliable access to innovative therapeutic wellness solutions. Asteria Health, based in the UK, provides pharmaceutical compounding solutions, including compounded bioidentical hormones.

Major companies operating in the bioidentical hormones market are Pfizer Inc., AbbVie Inc., Bayer AG, Abbott Laboratories Inc., Merck KGaA, Hikma Pharmaceuticals Plc, TherapeuticsMD Inc., Gedeon Richter Plc, Noven Pharmaceuticals Inc., AnazaoHealth Corp., Women's International Pharmacy Inc., Wells Pharmacy Network, ZRT Laboratory LLC, BionPharma Inc., Orion Pharma AB, Actiza Pharmaceutical Private Limited, Biostation, Advantage Pharmaceuticals Inc., Bravado Labs, Neuva Aesthetics, Papillon Medical, United Pharmacy LLC, SottoPelle Inc., Apotheca Compounding Pharmacy, MedQuest Pharmacy

North America was the largest region in the bioidentical hormones market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bioidentical hormones market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the bioidentical hormones market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The bioidentical hormones market includes revenues earned by entities by providing services such as personalized hormone level testing, compounding pharmacy services, anti-aging treatments, wellness and longevity programs, weight management support, and integrative health services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Bioidentical Hormones Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on bioidentical hormones market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for bioidentical hormones ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The bioidentical hormones market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Estrogen; Progesterone; Testosterone; Other Types
• 2) By Product Type: Tablet And Capsule; Cream And Gel; Patch And Implant; Injectable; Other Product Types
• 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Other Distribution Channels
• 4) By Application: Menopause Management; Hormone Replacement Therapy (HRT); Thyroid Disorders; Andropause Management
• 5) By End-use: Hospitals; Gynecology Clinics; Research Laboratories; Other End-Users
• Subsegments:
• 1) By Estrogen: Estrone (E1); Estradiol (E2); Estriol (E3); Bioidentical Estradiol Creams; Bioidentical Estrone Creams
• 2) By Progesterone: Bioidentical Progesterone Creams; Bioidentical Progesterone Capsules; Bioidentical Progesterone Injections
• 3) By Testosterone: Bioidentical Testosterone Creams; Bioidentical Testosterone Injections; Bioidentical Testosterone Pellets; Bioidentical Testosterone Gels
• 4) By Other Types: Dhea (Dehydroepiandrosterone); Thyroid Hormones (T3, T4); Cortisol; Melatonin; Human Growth Hormone (Hgh)
• Companies Mentioned: Pfizer Inc.; AbbVie Inc.; Bayer AG; Abbott Laboratories Inc.; Merck KGaA
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Bioidentical Hormones Market Characteristics

3. Bioidentical Hormones Market Trends And Strategies

4. Bioidentical Hormones Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Bioidentical Hormones Growth Analysis And Strategic Analysis Framework

• 5.1. Global Bioidentical Hormones PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Bioidentical Hormones Market Growth Rate Analysis
• 5.4. Global Bioidentical Hormones Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Bioidentical Hormones Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Bioidentical Hormones Total Addressable Market (TAM)

6. Bioidentical Hormones Market Segmentation

• 6.1. Global Bioidentical Hormones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Estrogen
• Progesterone
• Testosterone
• Other Types
• 6.2. Global Bioidentical Hormones Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tablet And Capsule
• Cream And Gel
• Patch And Implant
• Injectable
• Other Product Types
• 6.3. Global Bioidentical Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Other Distribution Channels
• 6.4. Global Bioidentical Hormones Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Menopause Management
• Hormone Replacement Therapy (HRT)
• Thyroid Disorders
• Andropause Management
• 6.5. Global Bioidentical Hormones Market, Segmentation By End-use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Gynecology Clinics
• Research Laboratories
• Other End-Users
• 6.6. Global Bioidentical Hormones Market, Sub-Segmentation Of Estrogen, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Estrone (E1)
• Estradiol (E2)
• Estriol (E3)
• Bioidentical Estradiol Creams
• Bioidentical Estrone Creams
• 6.7. Global Bioidentical Hormones Market, Sub-Segmentation Of Progesterone, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bioidentical Progesterone Creams
• Bioidentical Progesterone Capsules
• Bioidentical Progesterone Injections
• 6.8. Global Bioidentical Hormones Market, Sub-Segmentation Of Testosterone, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bioidentical Testosterone Creams
• Bioidentical Testosterone Injections
• Bioidentical Testosterone Pellets
• Bioidentical Testosterone Gels
• 6.9. Global Bioidentical Hormones Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Dhea (Dehydroepiandrosterone)
• Thyroid Hormones (T3, T4)
• Cortisol
• Melatonin
• Human Growth Hormone (Hgh)

7. Bioidentical Hormones Market Regional And Country Analysis

• 7.1. Global Bioidentical Hormones Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Bioidentical Hormones Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Bioidentical Hormones Market

• 8.1. Asia-Pacific Bioidentical Hormones Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Bioidentical Hormones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Bioidentical Hormones Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Bioidentical Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Bioidentical Hormones Market

• 9.1. China Bioidentical Hormones Market Overview
• 9.2. China Bioidentical Hormones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Bioidentical Hormones Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Bioidentical Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Bioidentical Hormones Market

• 10.1. India Bioidentical Hormones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Bioidentical Hormones Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Bioidentical Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Bioidentical Hormones Market

• 11.1. Japan Bioidentical Hormones Market Overview
• 11.2. Japan Bioidentical Hormones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Bioidentical Hormones Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Bioidentical Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Bioidentical Hormones Market

• 12.1. Australia Bioidentical Hormones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Bioidentical Hormones Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Bioidentical Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Bioidentical Hormones Market

• 13.1. Indonesia Bioidentical Hormones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Bioidentical Hormones Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Bioidentical Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Bioidentical Hormones Market

• 14.1. South Korea Bioidentical Hormones Market Overview
• 14.2. South Korea Bioidentical Hormones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Bioidentical Hormones Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Bioidentical Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Bioidentical Hormones Market

• 15.1. Western Europe Bioidentical Hormones Market Overview
• 15.2. Western Europe Bioidentical Hormones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Bioidentical Hormones Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Bioidentical Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Bioidentical Hormones Market

• 16.1. UK Bioidentical Hormones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Bioidentical Hormones Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Bioidentical Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Bioidentical Hormones Market

• 17.1. Germany Bioidentical Hormones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Bioidentical Hormones Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Bioidentical Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Bioidentical Hormones Market

• 18.1. France Bioidentical Hormones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Bioidentical Hormones Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Bioidentical Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Bioidentical Hormones Market

• 19.1. Italy Bioidentical Hormones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Bioidentical Hormones Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Bioidentical Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Bioidentical Hormones Market

• 20.1. Spain Bioidentical Hormones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Bioidentical Hormones Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Bioidentical Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Bioidentical Hormones Market

• 21.1. Eastern Europe Bioidentical Hormones Market Overview
• 21.2. Eastern Europe Bioidentical Hormones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Bioidentical Hormones Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Bioidentical Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Bioidentical Hormones Market

• 22.1. Russia Bioidentical Hormones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Bioidentical Hormones Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Bioidentical Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Bioidentical Hormones Market

• 23.1. North America Bioidentical Hormones Market Overview
• 23.2. North America Bioidentical Hormones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Bioidentical Hormones Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Bioidentical Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Bioidentical Hormones Market

• 24.1. USA Bioidentical Hormones Market Overview
• 24.2. USA Bioidentical Hormones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Bioidentical Hormones Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Bioidentical Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Bioidentical Hormones Market

• 25.1. Canada Bioidentical Hormones Market Overview
• 25.2. Canada Bioidentical Hormones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Bioidentical Hormones Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Bioidentical Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Bioidentical Hormones Market

• 26.1. South America Bioidentical Hormones Market Overview
• 26.2. South America Bioidentical Hormones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Bioidentical Hormones Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Bioidentical Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Bioidentical Hormones Market

• 27.1. Brazil Bioidentical Hormones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Bioidentical Hormones Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Bioidentical Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Bioidentical Hormones Market

• 28.1. Middle East Bioidentical Hormones Market Overview
• 28.2. Middle East Bioidentical Hormones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Bioidentical Hormones Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Bioidentical Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Bioidentical Hormones Market

• 29.1. Africa Bioidentical Hormones Market Overview
• 29.2. Africa Bioidentical Hormones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Bioidentical Hormones Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Bioidentical Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Bioidentical Hormones Market Competitive Landscape And Company Profiles

• 30.1. Bioidentical Hormones Market Competitive Landscape
• 30.2. Bioidentical Hormones Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Abbott Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis

31. Bioidentical Hormones Market Other Major And Innovative Companies

• 31.1. Hikma Pharmaceuticals Plc
• 31.2. TherapeuticsMD Inc.
• 31.3. Gedeon Richter Plc
• 31.4. Noven Pharmaceuticals Inc.
• 31.5. AnazaoHealth Corp.
• 31.6. Women's International Pharmacy Inc.
• 31.7. Wells Pharmacy Network
• 31.8. ZRT Laboratory LLC
• 31.9. BionPharma Inc.
• 31.10. Orion Pharma AB
• 31.11. Actiza Pharmaceutical Private Limited
• 31.12. Biostation
• 31.13. Advantage Pharmaceuticals Inc.
• 31.14. Bravado Labs
• 31.15. Neuva Aesthetics

32. Global Bioidentical Hormones Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Bioidentical Hormones Market

34. Recent Developments In The Bioidentical Hormones Market

35. Bioidentical Hormones Market High Potential Countries, Segments and Strategies

• 35.1 Bioidentical Hormones Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Bioidentical Hormones Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Bioidentical Hormones Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer